An E6 Oncoprotien Based Diagnostic Test for Cervical Pre-Cancer and Cancer

This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.

Publication date: July 2010

An E6 Oncoprotein Based Diagnostic Test for Cervical Pre-Cancer and Cancer (poster)

363.1 KB PDF
Hard copies are not available.
View Resource